Development · 5 Nov 2026
BIOCON, full dossier2 publishers have reported this development. Each act of reporting is below, cited.
Biocon reported a 51 per cent year-on-year decline in profit after tax to ₹41 crore in the second quarter, even as revenue rose 2.2 per cent to ₹4,389 crore.
Biocon's net profit fell 52 percent to Rs 41 crore in Q2 FY27.
16 Nov 2026 · 4 publishers
4 Nov 2026 · 1 publisher
27 Oct 2026 · 1 publisher
26 Oct 2026 · 1 publisher
This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.
New here? The reader's guide explains every page, plate by plate.
fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.